CDPRG discusses the UK’s Reschedule Psilocybin campaign
Currently in the UK psilocybin is categorised as a Schedule 1 drug under the Misuse of Drugs Act 2001 – the highest schedule alongside drugs such as raw opium and LSD.
This status makes research into the substance incredibly challenging as financial costs for licensing and laboratory retrofitting can be costly.
Although costly – some are successful in carrying out such research – and now, an increasing amount of studies are showing psychedelic compounds such as psilocybin, LSD, DMT and others as promising treatments for mental health conditions.
A recent debate in UK Parliament saw MP for Warrington North, Charlotte Nichols, lead calls for the rescheduling of psilocybin after describing her own experience living with PTSD.READ MORE